NASDAQ:ITMR

Itamar Medical Earnings Date, Estimates, & History

Notice: This company has been marked as potentially delisted and may not be actively trading.

$30.87

0.00 (0.00%)

(As of 12/16/2021)

Add

Compare

Today's Range: $30.87
▼
$30.87
50-Day Range: $30.54
▼
$30.87
52-Week Range: $16.36
▼
$30.91

Volume: N/A
Average Volume: 90,796 shs
Market Capitalization: $497.25 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 0.73

Upcoming
Earnings Date
Mar. 1
Estimated

Actual EPS
(Nov. 18)
-$0.49
Missed By -$0.32

Consensus EPS
(Nov. 18)
-$0.17

Last Year's Q4 EPS
(11/16/2020)
-$0.20

Earnings Per Share Revenue

Itamar Medical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Itamar Medical Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Itamar Medical (NASDAQ:ITMR) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2022	1	($0.19)	($0.19)	($0.19)
Q2 2022	1	($0.17)	($0.17)	($0.17)
Q3 2022	1	($0.17)	($0.17)	($0.17)
Q4 2022	1	($0.17)	($0.17)	($0.17)
FY 2022	4	($0.70)	($0.70)		($0.70)

ITMR Earnings Information

Itamar Medical last announced its quarterly earnings results on November 18th, 2021. The reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.32. The company had revenue of $13.57 million for the quarter, compared to analysts' expectations of $13.70 million. Itamar Medical has generated ($1.35) earnings per share over the last year (($1.35) diluted earnings per share). Earnings for Itamar Medical are expected to grow in the coming year, from ($1.20) to ($0.59) per share. Itamar Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 1st, 2022 based off prior year's report dates.

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
3/1/2022 (Estimated)
11/18/2021	9/30/2021	($0.17)	($0.49)	($0.32)	($0.49)	$13.70 million	$13.57 million
8/31/2021	Q2	($0.27)	($0.29)	($0.02)
8/10/2021	Q2 2021	($0.30)	($0.29)	+$0.01	($0.29)	$12.08 million	$12.56 million
5/18/2021	3/31/2021	($0.20)	($0.36)	($0.16)	($0.24)	$11.10 million	$11.98 million
3/2/2021	Q4 2020	($0.14)	($0.18)	($0.04)	($0.15)	$12.70 million	$12.77 million
11/16/2020	9/30/2020	($0.17)	($0.20)	($0.03)	($0.16)		$11.00 million
8/11/2020	Q2 2020	($0.21)	($0.22)	($0.01)	($0.21)	$7.92 million	$8.89 million
5/27/2020	Q1 2020	($0.17)	($0.15)	+$0.02	($0.15)	$8.40 million	$8.38 million
3/3/2020	Q4 2019	($0.10)	($0.06)	+$0.04	($0.03)	$9.68 million	$9.77 million
11/26/2019	Q3 2019		($0.09)	($0.09)	($0.08)		$8.08 million
8/14/2019	Q2 2019		($0.16)	($0.16)	($0.14)		$7.35 million

(Earnings results data provided by Zacks Investment Research)

Itamar Medical (NASDAQ:ITMR) Earnings Frequently Asked Questions

When is Itamar Medical's earnings date?: Itamar Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 1st, 2022 based off last year's report dates. Learn more on ITMR's earnings history
Did Itamar Medical beat their earnings estimates last quarter?: In the previous quarter, Itamar Medical (NASDAQ:ITMR) missed the analysts' consensus estimate of ($0.17) by $0.32 with a reported earnings per share (EPS) of ($0.49). Learn more on ITMR's earnings details

How much revenue does Itamar Medical generate each year?: Itamar Medical (NASDAQ:ITMR) has a recorded annual revenue of $41.03 million.
What is Itamar Medical's EPS forecast for next year?: Itamar Medical's earnings are expected to grow from ($1.20) per share to ($0.59) per share in the next year.

This page was last updated on 1/23/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.